نتائج البحث - "Beljkaš, Milan"

1

Academic Journal

Discovery of (3-Phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates as Imidazoline I2 Receptor Ligands with Anti-Alzheimer and Analgesic Properties

المصدر: Journal of Medicinal Chemistry

Relation: Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (Spain, PID2022-1380790B-I00 to C.E.; PID2021-138079OB-I00 to M.P.; MICIU/AEI/10.13039/501100011033; FEDER, UE; PDC2022-133441-I00 to C.E.; MICIU/AEI/10.13039/501100011033 Europea Next GenerationEU/PRTR); Basque Government (IT-1512-22); Generalitat de Catalunya (2021 SGR 00357); provided for A.L.-R. (PRE2022-105091 ministerio de Ciencia e Innovación); The Margarita Salas Program (Ministerio de Universidades; Plan de Recuperación, Transformación y Resilencia; NextGenerationEU) with the participation of the University of the Balearic Islands; grant FJC2022-048338-I; MCIN/AEI/10.13039/501100011033; The European Union NextGenerationEU/PRTR; The Ministry of Science and Innovation, Spain, with funds from the European Union NextGenerationEU (PRTRC17.I1); The Autonomous Community of Galicia within the framework of the 2023 Biotechnology Plan Applied to Health, Xunta de Galicia (ED431C 2022/20) and the European Regional Development Fund (ERDF); The Andalusian Regional Government (grant CTS-109); The Unit of Excellence “UNETE” from the University of Granada (reference UCE-PP2017-05); info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//; Grant PRE2022-105091; MICIU/AEI/10.13039/501100011033; https://farfar.pharmacy.bg.ac.rs/handle/123456789/5931; 001399648500001

الاتاحة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/5931
https://doi.org/10.1021/acs.jmedchem.4c01644
http://farfar.pharmacy.bg.ac.rs/bitstream/id/17239/discovery_of_3-phenylcarbamoyl-3-4-dihydro-2h-pyrrol-2-yl_pub_2025.pdf

View record in BASE

2

Conference

Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modeling

المؤلفون: Đoković, Nemanja, Ilić, Aleksandra, Čebzan, Alen, Radović, Branko, Ružić, Dušan, Beljkaš, Milan, Đurić, Ana, Srdić-Rajić, Tatjana, Oljačić, Slavica, Nikolić, Katarina

المصدر: EFMC-ISMC 2024, XXVIII EFMC International Symposium on Medicinal Chemistry, Rome, Italy, September 1-5, 2024, Book of Abstracts

مصطلحات موضوعية: HDAC inhibitors, PDAC, ROCK inhibitors, synergism

Relation: info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//; The authors thank the COST Actions CA18240, CA21135 and CA22125 of the European Community for support; https://farfar.pharmacy.bg.ac.rs/handle/123456789/5747; https://hdl.handle.net/21.15107/rcub_farfar_5747

الاتاحة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/5747
http://farfar.pharmacy.bg.ac.rs/bitstream/id/16624/Discovery_of_dual-acting_pub_2024.pdf
https://hdl.handle.net/21.15107/rcub_farfar_5747

View record in BASE

3

Academic Journal

Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design

المؤلفون: Beljkaš, Milan, Petković, Miloš, Vuletić, Ana, Đurić, Ana, Santibanez, Juan Francisco, Srdić-Rajić, Tatjana, Nikolić, Katarina, Oljačić, Slavica

المصدر: Pharmaceutics

مصطلحات موضوعية: breast cancer, 3D-QSAR, antineoplastic agents, molecular modeling, multitarget-directed ligands, pancreatic ductal adenocarcinoma, rational drug design, Rho-associated protein kinases

Relation: info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//; info:eu-repo/grantAgreement/MESTD/inst-2020/200043/RS//; info:eu-repo/grantAgreement/MESTD/inst-2020/200015/RS//; https://farfar.pharmacy.bg.ac.rs/handle/123456789/5817; 001342843300001; http://farfar.pharmacy.bg.ac.rs/bitstream/id/16846/Development_of_Novel_pub_2024.pdf

الاتاحة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/5817
https://doi.org/10.3390/pharmaceutics16101250
http://farfar.pharmacy.bg.ac.rs/bitstream/id/16846/Development_of_Novel_pub_2024.pdf

View record in BASE

4

Conference

Virtual Docking, design and in silico ADMET profiling of novel Rho- associated protein kinases-1 (ROCK1) inhibitors

المؤلفون: Beljkaš, Milan, Rebić, Jelena, Radan, Milica, Đikić, Teodora, Oljačić, Slavica, Nikolić, Katarina

المصدر: 2nd International Conference on Chemo and Bioinformatics ICCBIKG 2023, BOOK OF PROCEEDINGS

مصطلحات موضوعية: molecular docking, ADME, design, ROCK1

Relation: info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//; https://farfar.pharmacy.bg.ac.rs/handle/123456789/5041; http://farfar.pharmacy.bg.ac.rs/bitstream/id/13892/Virtual_Docking,_design_pub_2023.pdf

الاتاحة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/5041
https://doi.org/10.46793/ICCBI23.589B
http://farfar.pharmacy.bg.ac.rs/bitstream/id/13892/Virtual_Docking,_design_pub_2023.pdf

View record in BASE

5

Conference

3D-Quantitative Structure-Activity Relationship and design of novel Rho- associated protein kinases-1 (ROCK1) inhibitors

المؤلفون: Beljkaš, Milan, Rebić, Jelena, Radan, Milica, Đikić, Teodora, Oljačić, Slavica, Nikolić, Katarina

المصدر: 2nd International Conference on Chemo and Bioinformatics, BOOK OF PROOCEEDINGS

مصطلحات موضوعية: ROCK, cancer, 3D-QSAR, design

Relation: info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//; https://farfar.pharmacy.bg.ac.rs/handle/123456789/5043; http://farfar.pharmacy.bg.ac.rs/bitstream/id/13893/3D-Quantitative_Structure-Activity_Relationship_pub_2023.pdf

الاتاحة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/5043
https://doi.org/10.46793/ICCBI23.584B
http://farfar.pharmacy.bg.ac.rs/bitstream/id/13893/3D-Quantitative_Structure-Activity_Relationship_pub_2023.pdf

View record in BASE

6

Conference

Virtual docking and design of novel Histone deacetylase and Rho- associated protein kinases dual inhibitors (HDAC/ROCKs)

المؤلفون: Beljkaš, Milan, Petković, Miloš, Nikolić, Katarina, Oljačić, Slavica

المصدر: 10th IAPC Meeting Tenth World Conference on Physico-Chemical Methods in Drug Discovery & Sixth World Conference on ADMET and DMPK Belgrade, Serbia, September 4-6

مصطلحات موضوعية: HDAC inhibitors, Rho-associated protein kinases inhibitors, GOLD software, treatment of pancreatic ductal adenocarcinoma

Relation: info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//; https://farfar.pharmacy.bg.ac.rs/handle/123456789/5005; http://farfar.pharmacy.bg.ac.rs/bitstream/id/13769/Virtual_docking_and_pub_2023.pdf; https://hdl.handle.net/21.15107/rcub_farfar_5005

الاتاحة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/5005
http://farfar.pharmacy.bg.ac.rs/bitstream/id/13769/Virtual_docking_and_pub_2023.pdf
https://hdl.handle.net/21.15107/rcub_farfar_5005

View record in BASE

7

Academic Journal

Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease

المؤلفون: Bagán, Andrea, Rodriguez-Arévalo, Sergio, Taboada-Jara, Teresa, Griñán-Ferré, Christian, Pallàs, Mercè, Brocos Mosquera, Iria, Callado Hernando, Luis Felipe, Morales-García, José A., Pérez, Belén, Diaz, Caridad, Fernández-Godino, Rosario, Genilloud, Olga, Beljkas, Milan, Oljacic, Slavica, Nikolic, Katarina, Escolano, Carmen

مصطلحات موضوعية: imidazoline I2 receptor ligand, Alzheimer’s disease, imidazoline-linked heterocycle, 2-(benzo[b]thiophen-2-yl)-1H-imidazole, 5XFAD, 3D-QSAR, neuroprotection

وصف الملف: application/pdf

Relation: https://www.mdpi.com/1999-4923/15/10/2381; Pharmaceutics 15(10) : (2023) // Article ID 2381; http://hdl.handle.net/10810/63121

الاتاحة: http://hdl.handle.net/10810/63121
https://doi.org/10.3390/pharmaceutics15102381

View record in BASE

Full Text Finder

8

Academic Journal

Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer

المؤلفون: Beljkaš, Milan, Ilić, Aleksandra, Cebzan, Alen, Radović, Branko, Đoković, Nemanja, Ružić, Dušan, Nikolić, Katarina, Oljačić, Slavica

المصدر: Pharmaceutics

مصطلحات موضوعية: cancer, epigenetics, histone deacetylases, dual-target therapy, inhibitors, kinases, rational design

Relation: info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//; https://farfar.pharmacy.bg.ac.rs/handle/123456789/5339; 001118394000001; http://farfar.pharmacy.bg.ac.rs/bitstream/id/14950/Targeting_Histone_Deacetylases_pub_2023.pdf

الاتاحة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/5339
https://doi.org/10.3390/pharmaceutics15112581
http://farfar.pharmacy.bg.ac.rs/bitstream/id/14950/Targeting_Histone_Deacetylases_pub_2023.pdf

View record in BASE

9

Academic Journal

Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease

المؤلفون: BagÃ¡n, Andrea, Rodriguez-ArÃ©valo, Sergio, Taboada-Jara, Teresa, GriÃ±Ã¡n-FerrÃ©, Christian, PallÃ s, MercÃ¨, Brocos Mosquera, Iria, Callado, Luis F., Morales-GarcÃa, JosÃ© A., PÃ©rez, BelÃ©n, DÃaz Navarro, Caridad, FernÃ¡ndez-Godino, Rosario, Genilloud, Olga, Beljkas, Milan, Oljacic, Slavica, Nikolic, Katarina, Escolano, Carmen

مصطلحات موضوعية: Imidazoline I2 receptor ligand, Alzheimer's disease, Imidazoline-linked heterocycle, 2-(benzo[b]thiophen-2-yl)-1H-imidazole, 5XFAD, 3D-QSAR, Neuroprotection

وصف الملف: application/pdf

Relation: Agencia Estatal de InvestigaciÃ³n PID2019-107991RB-I00; Agencia Estatal de InvestigaciÃ³n PID2022-139180OB-I00; Agencia Estatal de InvestigaciÃ³n PID2022- 138079OB-I00; Agencia Estatal de InvestigaciÃ³n PDC2022-133441-I00; Pharmaceutics; Vol. 15 NÃºm. 10 (2023), p. 2381; https://ddd.uab.cat/record/288307; urn:10.3390/pharmaceutics15102381; urn:oai:ddd.uab.cat:288307; urn:oai:egreta.uab.cat:publications/30bc5b1e-be3f-4bf9-ba7e-2f0a193d4ca6; urn:pure_id:384327836; urn:pmid:37896141; urn:scopus_id:85175042972; urn:pmcid:PMC10610545; urn:articleid:19994923v15n10p2381; urn:oai:pubmedcentral.nih.gov:10610545; urn:pmc-uid:10610545

الاتاحة: https://ddd.uab.cat/record/288307

View record in BASE

Full Text Finder

10

Conference

Molecular modeling and design of new PI3K/HDAC dual inhibitors

المؤلفون: Beljkaš, Milan, Kukić, E, Đoković, Nemanja, Oljačić, Slavica

المصدر: PHYSICAL CHEMISTRY 2024, 17th International Conference on Fundamental and Applied Aspects of Physical Chemistry (Proceedings)

مصطلحات موضوعية: dual targeting, cancer, molecular docking, HDAC, PI3K

Relation: info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//; https://farfar.pharmacy.bg.ac.rs/handle/123456789/5912

الاتاحة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/5912
https://doi.org/10.46793/Phys.Chem24II.647B

View record in BASE

11

Academic Journal

Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation

المؤلفون: Ružić, Dušan, Ellinger, Bernhard, Đoković, Nemanja, Santibanez, Juan F., Gul, Sheraz, Beljkaš, Milan, Đurić, Ana, Ganesan, Arasu, Pavić, Aleksandar, Srdić-Rajić, Tatjana, Petković, Miloš, Nikolić, Katarina

المصدر: Pharmaceutics

مصطلحات موضوعية: 1-benzhydryl piperazine, anti-metastatic effect, breast cancer, drug discovery, histone deacetylases, hydroxamic acid, zebrafish xenograft model

Relation: info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//; info:eu-repo/grantAgreement/MESTD/inst-2020/200042/RS//; British Scholarship Trust Foundation for sup- port in Short term research grant at the University of East Anglia, Norwich, United Kingdom; OST-Action CM1406 “Epigenetic Chemical Biol- ogy” (EpiChemBio); http://rimi.imi.bg.ac.rs/handle/123456789/1271; http://rimi.imi.bg.ac.rs/bitstream/id/2870/Discovery_of_1-Benzhydryl-Piperazine-Based_HDAC_Inhibitors_pub_2022.pdf

الاتاحة: http://rimi.imi.bg.ac.rs/handle/123456789/1271
https://doi.org/10.3390/pharmaceutics14122600
http://rimi.imi.bg.ac.rs/bitstream/id/2870/Discovery_of_1-Benzhydryl-Piperazine-Based_HDAC_Inhibitors_pub_2022.pdf

View record in BASE

Full Text Finder

12

Conference

Is there a borderline between cytotoxic and antimetastatic effects of selective Histone deacetylase 6 inhibitors in solid malignancies? ; Постоји ли граница између цитотоксичног и антиметастатског ефекта селективних инхибитора хистон деацетилазе 6 код солидних тумора?

المؤلفون: Nikolić, Katarina, Ružić, Dušan, Beljkaš, Milan, Petković, Miloš, Gul, Sheraz, Santibanez, Juan, Srdić Rajić, Tatjana

المصدر: 56th Cancerology week, Hotel Crowne plaza, November, 6 - 9. 2019, Belgrade, Serbia

مصطلحات موضوعية: epigenetic drugs, histone deacetylase 6 inhibitors, antimetastastic agents, adjuvant chemotherapy, епигенетски лекови, инхибитори хистон деацетилазе 6, антиметастатски агенси, адјувантни хемотерапеутици

Relation: info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172033/RS//; https://farfar.pharmacy.bg.ac.rs/handle/123456789/4928; http://farfar.pharmacy.bg.ac.rs/bitstream/id/13535/Is_there_a_borderline_pub_2019.pdf; https://hdl.handle.net/21.15107/rcub_farfar_4928

الاتاحة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/4928
http://farfar.pharmacy.bg.ac.rs/bitstream/id/13535/Is_there_a_borderline_pub_2019.pdf
https://hdl.handle.net/21.15107/rcub_farfar_4928

View record in BASE

13

Academic Journal

Anticancer evaluation of the selected tetrahydropyrimidines: 3D-QSAR, cytotoxic activities, mechanism of action, DNA, and BSA interactions

المؤلفون: Milović Emilija, Petronijević Jelena, Joksimović Nenad, Beljkaš Milan, Ružić Dušan, Nikolić Katarina, Vraneš Milan, Tot Aleksandar, Đorđić Crnogorac Marija, Stanojković Tatjana, Janković Nenad

المصدر: J Mol Struct, 1257, Article 132621, (2022-02-11)

مصطلحات موضوعية: Selected tetrahydropyrimidines (THPMs), B7 and B8, cytotoxic activity, molecular docking, DNA, BSA, 3D-QSAR model

Relation: https://doi.org/10.1016/j.molstruc.2022.132621; https://zenodo.org/communities/iors; oai:zenodo.org:7323174

الاتاحة: https://doi.org/10.1016/j.molstruc.2022.132621

View record in BASE

14

Electronic Resource

Anticancer evaluation of the selected tetrahydropyrimidines: 3D-QSAR, cytotoxic activities, mechanism of action, DNA, and BSA interactions

المؤلفون: Milović, Emilija, Milović, Emilija, Petronijević, Jelena, Joksimović, Nenad, Beljkaš, Milan, Ružić, Dušan, Nikolić, Katarina, Vraneš, Milan, Tot, Aleksandar, Đorđić Crnogorac, Marija, Stanojković, Tatjana, Janković, Nenad

المصدر: Journal of Molecular Structure

URL: info:eu-repo/grantAgreement/MESTD/inst-2020/200122/RS
info:eu-repo/grantAgreement/MESTD/inst-2020/200378/RS
info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS